SERENITY - Cancer Associated Thrombosis Clinical Decision Support Tool - Named by Leiden as: Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life

Supported

Prof Erik Klok (Netherlands), co-CI Prof Simon Noble, Prof Annmarie Nelson, Prof Adrian Edwards

Leiden University

£3,898,878

EU Horizon Health

2021-2022

Open

Click here